NCT01814956

Different Lipid Emulsions in Acute Lung Injury Patients

Prospective, Randomized, Controlled, Double-blind, Parallel-group, Mono-center, Explorative Phase IV Trial on the Efficacy and Safety of a Fish Oil Containing Lipid Emulsion Versus a Standard Soybean-oil Based Lipid Emulsion in Patients With Acute Lung Injury

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 1 (actual)
• Sponsor: B. Braun Melsungen AG · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Aim is to investigate the influence of an early supply of parenteral nutrition including a fish oil containing lipid emulsion on the course of acute lung injury in the intensive care unit. In comparison, a standard parenteral nutrition with a soybean oil based emulsion will be used. Data obtained in this trial may provide evidence for a beneficial effect of fish oil derived omega-3 fatty acids in parenteral nutrition regarding their influence on acute lung injury.

Conditions

• Parenteral Nutrition

Interventions

Type	Name	Description
DRUG	Lipoplus 20%	Lipoplus 20% (MCT/LCT/FO) i.v. lipid emulsion for parenteral nutrition
DRUG	Lipofundin N 20%	Lipofundin N 20% (LCT, soy bean oil) i.v. lipid emulsion for parenteral nutrition

Timeline

• Start date: 2013-03-01
• Primary completion: 2015-05-01
• Completion: 2015-05-01
• First posted: 2013-03-20
• Last updated: 2016-07-20

Locations

1 site across 1 country: Germany